ABSTRACT

The diagnosis of pulmonary embolism is still difficult, because it may occur with different symptoms and signs. These cases can be admitted to the emergency department with shock, syncope or cardiopulmonary arrest. More than 70 percent of cardiopulmonary arrest cases are caused by acute myocardial infarction or massive pulmonary embolism and it has a poor prognosis. We present two cases of massive pulmonary embolism requiring cardiopulmonary resuscitation and administered thrombolytic agents. Two patients received 10 mg bolus of recombinant tissue-type plasminogen activator (alteplase) followed by 90 mg intravenous infusion for two hours. Rapid clinical and hemodynamic improvement occurred after thrombolytic injection and the patients were discharged from the hospital.

In case of suspicion of massive pulmonary embolism in cardiopulmonary arrest cases, thrombolytic agents should be administered during cardiopulmonary resuscitation. This procedure will treat the condition caused by arrest and also is shown to have beneficial effects on the early microcirculatory cerebral reperfusion and to prevent neurological sequelae.

Keywords: Pulmonary embolism, cardiopulmonary arrest, resuscitation, alteplase

References

Bailén MR, Cuadra JA, Aguayo De Hoyos E. Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: a review. Crit Care Med 2001;29:2211-9.

Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. A scientific statement from the American Heart Association. Circulation 2011;123:1788-830.

Truhlář A, Deakin CD, Soar J, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances. Resuscitation 2015;95:148-201.

Martin C, Sobolewski K, Bridgeman P, et al. Systemic Thrombolysis for Pulmonary Embolism: A Review. P T. 2016;41:770-5.

Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014;311:2414-21.

Peters NA, Paciullo CA. Alteplase for the Treatment of Pulmonary Embolism: A Review. Adv Emerg Nurs J 2015;37:258-72.

Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.

Uçar EY. Thrombolitic treatment. Türkiye Klinikleri J Pulm Med-Special Topics 2016;9:39-43.

O’Connor G, Fitzpatrick G, El-Gammal A, et al. Double Bolus Thrombolysis for Suspected Massive Pulmonary Embolism during Cardiac Arrest. Case Rep Emerg Med 2015;2015:367295.

Curtis GM, Lam SW, Reddy AJ, et al. Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study. Pharmacotherapy 2014;34:818-25.

Virk HUH, Chatterjee S, Sardar P, et al. Systemic Thrombolysis for Pulmonary Embolism: Evidence, Patient Selection, and Protocols for Management. Interv Cardiol Clin 2018;7:71-80.

Smithburger PL, Campbell S, Kane-gill SL. Alteplase treatment of acute pulmonary embolism in the intensive care unit. Crit Care Nurse 2013;33:17-27.

Hasanoglu HC. Thrombolitic treatment: Who, when, how? Guncel Gogus Hastaliklari Serisi 2015;3:34-44.

Böttiger BW, Arntz HR, Chamberlain DA, et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 2008;359:2651-62.

Condliffe R, Elliot CA, Hughes RJ, et al. Management dilemmas in acute pulmonary embolism. Thorax 2014;69:174-80.

Thrombolytic Use During Cardiopulmonary Arrest in Massive Pulmonary Embolism: Return to Life of Two Patients

ABSTRACT

References